The Influenza A Virus NS1 Protein Inhibits Activation of Jun N-Terminal Kinase and AP-1 Transcription Factors

ABSTRACT The influenza A virus nonstructural NS1 protein is known to modulate host cell gene expression and to inhibit double-stranded RNA (dsRNA)-mediated antiviral responses. Here we identify NS1 as the first viral protein that antagonizes virus- and dsRNA-induced activation of the stress response-signaling pathway mediated through Jun N-terminal kinase.

Cells respond to a variety of stress conditions such as UV irradiation and endotoxin exposure by activation of Jun Nterminal kinase (JNK) (also termed stress-activated protein kinase [SAPK]), which in turn phosphorylates and thereby upregulates the activity of transcription factors of the AP-1 family (21,44). JNK activation is also critical in the innate response to acute viral infections, because JNK-dependent AP-1 factors transactivate several antiviral and proinflammatory cytokine genes following infection. Importantly, the AP-1 heterodimer c-Jun::ATF-2 cooperates with the transcription factors NF-B and IRF to transactivate the beta interferon (IFN-␤) gene (40,43). Secretion of IFN-␤ is the initial event that triggers the expression of several IFN-dependent gene products with antiviral activity (7,15,38). One of the main triggering agents of this reaction is thought to be doublestranded RNA (dsRNA) produced during viral replication, because synthetic dsRNA is capable of activating JNK and the IFN system (5,18,31). However, neither the activating structures in viral RNAs nor their intracellular localization has been precisely identified.
It has been proposed that the influenza A virus NS1 protein is a viral regulator of gene expression that inhibits pre-mRNA processing and nucleocytoplasmic export of cellular mRNAs and enhances translation (1,4,6,9,10,25,28,33,34,46). On the other hand, the NS1 protein, which has RNA-binding activity (16), was also shown to antagonize antiviral dsRNAdependent enzymes and processes. These include activation of protein kinase R (PKR) (2,17,29) and of the transcription factors NF-B, IRF-3, and IRF-7 (37,39,42). As a result, the NS1 protein effectively restrains IFN-␣/␤ functions in infected cells (12). Recently, we and others have shown that influenza A virus replication stimulates the transcriptional activity of nuclear AP-1 factors and their target genes via the MKK4/7-JNK pathway (22,27,30). Moreover, these studies suggested that induction of AP-1 factors is detrimental to virus production, because expression of dominant-negative mutants of JNK or its substrate c-Jun increased viral titers (30). Thus, the question was raised whether the NS1 protein might affect this cellular response.
Influenza virus-induced JNK and c-Jun activation is upregulated in the absence of NS1 protein.
To study the role of the NS1 protein in JNK activation, we compared the influenza A/PR/8/34 wild-type (WT) virus with its two isogenic variants delNS1 and NS-IAmut1, which were generated by the ribonucleoprotein transfection method (12,42). The delNS1 virus completely lacks the NS1 gene, whereas NS-IAmut1 expresses an NS1 protein of wild-type length (230 amino acids) with five amino acid replacements at positions 181 to 185 (LIGGL to KQRRS). These mutations mediate a shift from a nuclear to a predominantly cytoplasmic NS1 localization in infected and transfected cells and slightly slow migration on sodium dodecyl sulfate (SDS)-polyacrylamide gels ( Fig. 1A to E). The introduced amino acid changes do not appear to alter the general structure of the viral NS1 protein because they do not affect its dimerization as judged by binding of the NS-IAmutI protein to corresponding glutathione S-transferase (GST)-NS1 mutant or WT fusion proteins (Fig. 1F). Also, the mutation did not reduce the ability of the NS1 protein to form stable complexes with dsRNA (Fig. 1G). Currently we cannot tell whether the altered intracellular localization of the NS-IAmutI protein is the consequence of an enhanced activity of the proposed nuclear export signal at NS1 amino acids 138 to 147 (26) or, rather, is due to cytoplasmic retention. However, replication of the NS-IAmutI virus seems not to be compromised by the mutation since the variant could be grown to titers of up to 10 8 PFU/ml in embryonated chicken eggs, which is comparable to WT growth (data not shown).
Permissive Vero cells were infected with WT and mutant viruses, and cell lysates were analyzed for JNK activation and phosphorylation of its downstream effector c-Jun at 4 and 8 h postinfection ( Fig. 2A). While JNK activity and c-Jun phoshorylation increased only moderately on infection with the WT and NS-IAmut1 viruses, these parameters were strongly enhanced by the delNS1 virus. These results suggest that expres-sion of nuclear and/or cytoplasmic NS1 proteins opposes signaling through the JNK pathway. Furthermore, we conclude that JNK activation is not mediated by an autocrine I IFN-␣/␤ loop, since Vero cells are deficient in IFN production (8).
FIG. 1. Expression, localization, dimerization, and dsRNA-binding of NS1 proteins encoded by influenza A/PR/8/34 WT and NS-IAmut1 viruses. (A) MDCK cells were infected with WT or NS-IAmut1 viruses. After a 5-h incubation at 37°C, the cells were metabolically labeled with [ 35 S]methionine for 1 h and lysed in RIPA buffer. The NS1 proteins were immunoprecipitated from total-cell lysates with rabbit anti-NS1 serum and analyzed by SDS-gel electrophoresis and autoradiography as described previously (45). The positions of the M1, NP, and NS1 proteins are indicated on the left and right. T, 10% of cell lysate used for immunoprecipitation. (B to E) Intracellular NS1 localization was determined by indirect immunofluorescence analysis of HeLa cells infected with WT (B) or NS-IAmutI (C) virus. Cells were fixed and permeabilized, and the NS1 proteins were detected by the use of rabbit anti-NS1 serum and anti-rabbit immunoglobulin G (IgG)-fluorescein isothiocyanate (FITC) conjugate as described elsewhere (45). The localization of NS1 proteins in the absence of virus infection was determined in MDCK cells after Lipofectamine 2000 (Invitrogen)-mediated transfection with mammalian pcDNA3.1-Myc/His expression plasmids (Invitrogen) encoding NS1 WT (D) or IAmut1 (E) protein. Cells were prepared for microscopic analysis, and the NS1 proteins were visualized by indirect immunofluorescence using the Myc-tag specific antibody 9E10 (Santa Cruz Biotechnology) and secondary FITC-conjugated anti-mouse IgG. The cells were viewed under a Nikon Axiophot 300 microscope equipped with an epifluorescence attachment. Images were recorded by a SPOT RT digital camera and processed using Adobe Photoshop 5.0 software. (F) To assess dimerization of NS1 proteins, equal amounts of GST, GST-NS1, and GST-NS-IAmut1 proteins were immobilized on glutathione-agarose beads and reacted with NS1 WT or NS-IAmut1 (mut) proteins that were synthesized in coupled transcription-translation reactions in the presence of [ 35 S]methionine as described previously (45). The precipitated proteins were separated by SDS-gel electrophoresis and visualized by autoradiography. T, 10% of the total amount used for precipitation. (G) Binding of GST-NS1 fusion proteins (0.4 M) to dsRNA (approximately 0.5 nM) derived from complementary 32 P-labeled transcripts of the polylinker region of plasmid pGEM-11zf (Promega) was examined as described previously (28). Protein-RNA complexes formed in the absence or presence of GST, GST-NS1 WT and GST-NS-IAmutI proteins were separated from free RNA by gel electrophoresis on a nondenaturing 10% polyacrylamide gel. The positions of free and complexed RNAs are indicated to the right.  delNS1 virus (Fig. 3A). This comparison showed that NS1 expression reduced viral promoter activation in our experimental setting by approximately threefold. Thus, virusinduced hyperphosphorylation of c-Jun in the absence of NS1 (Fig. 2) correlated with enhanced transcriptional activity of AP-1 factors. We confirmed that JNK and c-Jun are involved in delNS1-mediated IFN-␤ promoter activation by transfecting cells, prior to infection, with empty vector or plasmids expressing either dominant-negative JNK (SAPK␤ KKϾRR) or dominant-negative c-Jun (TAM67) (Fig. 3B). Coexpression of the two mutants decreased reporter gene activity, demonstrating that activation of the IFN-␤ promoter in delNS1 virus-infected cells requires activation of the JNK pathway. Inhibition was less pronounced than in cells expressing the NS1 protein (Fig.  3B). This outcome is consistent with additional inhibitory effects of NS1 on NF-B and IRF-3 activity in IFN-␤ induction (39,42), while the JNK and c-Jun mutants act only on a single pathway. Given the large number of genes that are regulated by AP-1 factors, the NS1 protein is likely to suppress activation not only of the IFN-␤ promoter but also of other target genes.
The NS1 protein inhibits dsRNA-mediated JNK activation. We finally examined whether NS1 expression would regulate JNK and AP-1 activation by dsRNA or other known stimuli. Cells were transfected with a plasmid encoding a GST-JNK fusion protein, together with NS1 expression constructs or empty vector. Subsequently, the cells were mock treated or stimulated with synthetic dsRNA and analyzed for JNK activity. Figure 4 shows that both the predominantly nuclear NS1 WT and the predominantly cytosolic IAmut1 protein almost completely prevented JNK activation (compare lanes vector with lanes WT and IAmut1). These results are consistent with the observations made during virus infections (Figs. 1 and 2). These findings were unexpected because influenza virus replication during which dsRNA might be generated by hybridization of genomic and antigenomic RNA strands is most prob- ably a nuclear event (23). Possibly, this instead indicates that NS1 inhibits JNK activation by association with intramolecularly base-paired regions in viral RNAs that are exported to the cytoplasm. Such an interaction has been demonstrated previously (32). Accordingly, expression of the NS1 protein carrying the R38A/K41A double mutation that attenuates binding to dsRNA (39, 41) did not prevent JNK activation (Fig. 4A, lanes R38AK41A). This finding gives additional support to the conclusion that the NS1 protein antagonizes JNK activation by virtue of its dsRNA-binding activity. However, we cannot rule out the possibility that interactions between NS1 and the cellular protein(s) involved in dsRNA-mediated activation of JNK play a role in the prevention of JNK activation. The specificity of the NS1 WT in repressing virus-and dsRNA-dependent responses was shown by its inability to inhibit JNK activation by the classical inducer sodium arsenite (Fig. 4B). Influenza virus infection and dsRNA treatment trigger specific signal transduction cascades that culminate in posttranscriptional activation of AP-1 and other transcription factors (11,30). This leads to the expression of antiviral (e.g., IFN-␣/ ␤), proinflammatory (e.g., tumor necrosis factor alpha and interleukin-6), and chemotactic (e.g., RANTES) cytokines that combine to shape the innate and adaptative immune response of mammals toward the intruding virus (3,20). Activation of JNK and c-Jun have also been linked to the induction of apoptosis (reviewed in reference 36), which is known to occur during influenza virus infection (22,35). Thus, inhibition of JNK-dependent responses by the NS1 protein is in the interest  IAmut1, and R38A K41A, respectively). At 24 h later, the cells were left untreated or stimulated with synthetic dsRNA (50 g/ml) for 6 h and extracts were prepared as described previously (30). JNK activity was assessed in the lysates by immune complex kinase assays using GST-c-Jun(1-135) as a substrate (30). The amount of GST-JNK in each sample was determined by immunoblotting with GST-specific antiserum. (B) In parallel reactions, we analyzed c-Jun phosphorylation in cells that were transfected with empty or NS1 expression vector and were mock treated (lane 0) or stimulated with 0.5 mM sodium arsenite, a common JNK activator, for 30 min (lanes 0.5).
VOL. 76, 2002 NOTES of efficient viral replication and spread and is likely to influence viral pathogenicity. We suggest that the lack of JNK inhibition contributes to the strong attenuation of the delNS1 virus in IFN-competent hosts and to its increased propensity to induce apoptosis (12,48).
The present characterization of NS1 as a specific antagonist of virus-and dsRNA-induced activation of JNK and its downstream targets is, to our knowledge, the first report of such a property of a viral protein. We speculate that other viruses express gene products that are functionally equivalent to NS1. This hypothesis is supported by the recent finding that the rotavirus VP8* protein can block TRAF2-dependent JNK activation, although it is not known if this occurs during virus infection (24). JNK activity is regulated by phosphorylation through the dual-specificity kinases MKK4 and MKK7, which are controlled by farther upstream regulators (13). PKR and 2Ј,5Ј-oligoadenylate synthetase have been implicated as potential dsRNA and/or viral RNA sensors that signal for JNK activation, but alternative pathways appear to exist (14,18,19). Based on the failure to inhibit JNK activation by chemotoxic stress and due to its dsRNA-binding capability, the NS1 protein is likely to exert its inhibitory function through its dsRNAbinding properties. Mechanistically, this would resemble the effect of NS1 in preventing the activation of NF-B and IRF-3 (39,42), although those factors may be controlled by at least partially different upstream sensors. For instance, genetic knockout of PKR ablated activation of NF-B but not of JNK or IRF-3 in response to virus infections in mouse fibroblasts (5,37). Whether the NS1-mediated inhibition of the JNK pathway is mediated by mere sequestration of dsRNA or by targeting of cellular dsRNA-sensor molecules through binding to shared dsRNA molecules will be a matter of future investigations. Taken together, our results characterize the NS1 protein as an antagonist of virus-and dsRNA-induced activation of JNK and AP-1. The precise identification of all the factors and pathways that participate in the induction of cytokine and chemokine genes in response to influenza virus infection remains an important challenge for future research. S.L., X.W., and C.E. contributed equally to this work. We thank Takashi Fujita (Tokyo, Japan) for providing plasmid p125-Luc. This work was supported by grants from the Deutsche Forschungsgemeinschaft (S.L., O.P., and S.P.) and the NIH (A.G.-S.).